Key takeaways:
Ketamine (Ketalar) is an intravenous (IV) medication that’s sometimes used for hard-to-treat depression. But it’s not FDA approved for this use. IV ketamine should only be given under medical supervision.
Mild ketamine side effects include drowsiness, nausea, and feeling strange or disoriented. Hallucinations, blood pressure spikes, and breathing problems can also occur. Most ketamine side effects go away within a few hours.
Tell your healthcare provider about other medications you take and your medical conditions. Ketamine treatments may not be safe if you have a higher risk for substance misuse, schizophrenia, or heart problems.
It can be extremely challenging if you’re struggling to find an antidepressant that helps your depression symptoms. If you’ve tried many antidepressants but they aren’t working, you may have treatment-resistant depression.
There are a few options for managing treatment-resistant depression. One unique option is ketamine (Ketalar), an injectable medication that’s FDA approved as a surgical anesthesia medication. At lower doses, ketamine is used off-label for treatment-resistant depression. But this comes with risks. Though it can rapidly improve depression symptoms, ketamine side effects are also possible.
Good to know: Spravato (esketamine) is a ketamine-based nasal spray. It’s FDA approved as an add-on treatment to traditional antidepressants for people with treatment-resistant depression or depression with suicidal thoughts or behavior. We’ll focus on intravenous (IV) ketamine in this article, but another GoodRx article covers Spravato side effects in depth.
Ketamine side effects usually go away within 4 hours. But its antidepressant effects may last several weeks with repeat doses.
Common/mild ketamine side effects include:
Drowsiness
Dissociation (feeling disconnected from your thoughts and surroundings)
Dizziness
Disorientation
Nausea and vomiting
Temporarily increased anxiety
Numbness
Blurred vision
Difficulty speaking
Rare but serious side effects may include:
High blood pressure
Heart problems
Trouble breathing, leading to death in rare cases
Hallucinations
Loss of consciousness
Dependence and misuse
Serious ketamine side effects are less likely with doses used in depression. They’re more likely with higher doses of ketamine used for anesthesia. Still, ketamine has significant risks to know about. We’ll dive deeper into eight of these side effects below.
Good to know: Ketamine isn’t recommended during pregnancy. And ketamine hasn't been studied for depression in adolescents. So this article is referring to side effects of ketamine use in non-pregnant adults only.
At higher doses, ketamine is used as an anesthesia for anything from small procedures to major surgeries. This means it causes sedation or complete loss of consciousness. Dissociation can occur with the lower doses of ketamine used for depression. This is a trance-like state of feeling disconnected from your body or the world around you.
You might start feeling strange or woozy as ketamine enters your system. Hallucinations, numbness, and temporarily losing the ability to speak are also possible. This is part of the reason your healthcare provider will monitor you for a few hours after receiving ketamine. By the time you leave, you should no longer be feeling any dissociative effects.
Arrange for someone to drive you home after your ketamine treatment. Having a support person to stay with you is a good idea, too. If you have any unusual experiences or still feel strange the next day, let your provider know.
Drowsiness is one the most common side effects of ketamine. So it’s a good idea to take it easy for the rest of the day following your ketamine treatment. This includes avoiding activities that require alertness, like driving or caring for a small child.
If you take other medications that cause drowsiness, excessive sleepiness may be more likely. Give your healthcare provider a complete list of all the medications you take before receiving ketamine. This will help them check for ketamine interactions that may worsen drowsiness.
Many people report dizziness after receiving ketamine. Dizziness is temporary, but be careful to avoid falls and injuries. Some tips include:
Make sure your walkways at home are cleared of tripping hazards.
Consider having someone stay with you the day you have treatment. They can help you get around and make sure you feel steady on your feet.
Take your time changing positions (like standing up) or changing direction (like turning around while walking). These movements can provoke dizziness spells.
Stay well hydrated. Dehydration can contribute to dizziness.
If dizziness from ketamine doesn’t improve while in your healthcare provider’s office, let your provider know. They may want to monitor you for longer before you go home.
Nausea is one of the most commonly reported side effects of ketamine. Your healthcare provider will likely advise you to avoid eating and drinking in the hours before your infusion to help prevent nausea and vomiting. The specific timing may vary by clinic.
If you experience vomiting from ketamine, your healthcare provider may recommend a medication to help, such as ondansetron (Zofran). Or they may have you take the medication in advance of your ketamine dose if you’re prone to feeling queasy.
It’s a good idea to have foods or drinks that usually settle your stomach available at home after your ketamine treatment. And make sure to stay hydrated. Dehydration can make nausea worse.
Ketamine can raise your blood pressure. Changes in blood pressure are usually minor, but they’re more likely with higher doses. And larger increases in blood pressure might be possible if you receive ketamine with other medications that increase blood pressure or if you have uncontrolled high blood pressure already.
Your medical provider will check your vital signs before, during, and after your ketamine dose. If your blood pressure is too high, they may delay ketamine treatment or give you medication to bring it down. Up to 20% of people receiving IV ketamine for depression may require blood pressure medication during their infusion.
Working with your healthcare provider to manage your blood pressure before ketamine treatment is important. Extremely high blood pressure can cause organ damage. Get medical help immediately if you experience chest pain, trouble breathing, or severe dizziness after leaving the clinic.
Good to know: Other heart problems, like abnormal heart rhythm, are also possible with IV ketamine. So let your healthcare provider know if you have any existing heart conditions.
Ketamine can slow your breathing — but this is rare. It’s more likely if you’re given ketamine for sedation or anesthesia or if you take other medications that slow breathing. Examples include:
Benzodiazepines like alprazolam (Xanax)
Opioids like hydrocodone
Muscle relaxers like cyclobenzaprine
Barbiturates like phenobarbital
Alcohol
Give your healthcare provider and pharmacist an updated list of the medications you take. They may recommend avoiding certain medications if you receive ketamine. And your provider will monitor your vital signs to make sure you're breathing normally before you go home.
Ketamine might help reduce any suicidal thoughts with your depression. But ketamine treatments don't work for everyone. And it’s possible to develop new thoughts of self-harm after starting treatment.
Stay in close contact with your healthcare provider or loved one being treated with ketamine. Be on the lookout for warning signs of suicidal ideation. And get help right away if you notice any of them.
Good to know: If your loved one is experiencing suicidal thoughts, find tips on how to talk to them about it in this video.
If you or someone you know is having thoughts of suicide, you’re not alone, and help is available. Call the National Suicide Prevention Lifeline at 988, or text HOME to 741-741 to reach the Crisis Text Line.
Ketamine is a controlled substance because it has a risk of dependence and misuse. In fact, ketamine misuse is increasing in the U.S.
It’s unlikely that ketamine treatments for depression given in medical settings will lead to misuse. But people with a past or present substance use disorder may be at greater risk.
Ketamine misuse may be more likely if it’s used at home. The FDA recently warned against home-use of ketamine pills or nasal sprays made by compounding pharmacies. Ketamine misuse can cause dangerous adverse effects, including trouble breathing and “ketamine bladder” — bladder inflammation that may lead to kidney damage.
If you or someone you know struggles with substance use, help is available. Call SAMHSA’s National Helpline at 1-800-662-4357 to learn about resources in your area.
Most ketamine side effects are short lived. But let your healthcare provider know if you notice any lingering symptoms after you get home from the clinic.
Get medical help right away if you notice any of the following:
Severe mood changes
Disorientation, or altered sense of reality
Trouble urinating
Pink or red urine
Chest pain
Severe dizziness
Trouble breathing
Thoughts of self-harm
Common ketamine side effects include drowsiness, dizziness, and nausea. It can also cause dissociative side effects that may make you feel strange or spacey. Rare but serious side effects from ketamine treatments include hallucinations, breathing problems, and misuse.
Your healthcare provider will monitor you for a few hours after your ketamine infusion. Most side effects should resolve within this timeframe. But to be safe, avoid driving the rest of the day after your treatment. And avoid other activities that require alertness. If you still feel “off” the next day or you’re having thoughts of self-harm, contact your healthcare provider and get medical help.
Abbar, M., et al. (2022). Ketamine for the acute treatment of severe suicidal ideation: Double blind, randomised placebo controlled trial. British Medical Journal.
Anand, A., et al. (2023). Ketamine versus ECT for nonpsychotic treatment-resistant major depression. The New England Journal of Medicine.
Anderson, D. J., et al. (2022). Ketamine-induced cystitis: A comprehensive review of the urologic effects of this psychoactive drug. Health Psychology Research.
Gómez-Revuelta, M., et al. (2020). Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression. Therapeutic Advances in Psychopharmacology.
Kritzer, M. D., et al. (2022). Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress. Annals of Clinical Psychiatry.
Krystal, J. H., et al. (2023). Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments. Proceedings of the National Academy of Sciences of the United States of America.
Langmia, I. M., et al. (2022). Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant - implications for precision dosing in a global perspective. British Journal of Clinical Pharmacology.
McIntyre, R. S., et al. (2021). Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. American Journal of Psychiatry.
Moore, T. J., et al. (2022). Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review. Pharmacotherapy.
National Institutes of Health. (2019). Side effects mild, brief with single antidepressant dose of intravenous ketamine.
Nikolin, S., et al. (2023). Ketamine for the treatment of major depression: A systematic review and meta-analysis. The Lancet.
Palamar, J. J., et al. (2021). Trends in ketamine use, exposures, and seizures in the United States up to 2019. American Journal of Public Health.
Riccardi, A., et al. (2023). Narrative review: Low-dose ketamine for pain management. Journal of Clinical Medicine.
Tian, F., et al. (2023). Characterizing brain dynamics during ketamine-induced dissociation and subsequent interactions with propofol using human intracranial neurophysiology. Nature Communications.
U.S. Department of Veterans Affairs. (2022). Ketamine infusion for treatment resistant depression and severe suicidal ideation.
U.S. Food and Drug Administration. (2022). FDA alerts health care professionals of potential risks associated with compounded ketamine nasal spray.
U.S. Food and Drug Administration. (2023). FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders.
Wan, L. B., et al. (2015). Ketamine safety and tolerability in clinical trials for treatment-resistant depression. Journal of Clinical Psychiatry.
Yip, R., et al. (2022). Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management. Frontiers in Psychiatry.
For additional resources or to connect with mental health services in your area, call SAMHSA’s National Helpline at 1-800-662-4357. For immediate assistance, call the National Suicide Prevention Lifeline at 988, or text HOME to 741-741 to reach the Crisis Text Line.